Malade Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 09-07-2024
- Paid Up Capital ₹ 2.00 M
as on 09-07-2024
- Company Age 34 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.30 M
as on 09-07-2024
- Revenue 29.41%
(FY 2022)
- Profit 11.53%
(FY 2022)
- Ebitda 13.39%
(FY 2022)
- Net Worth 23.91%
(FY 2022)
- Total Assets 9.49%
(FY 2022)
About Malade Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹6.30 M.
Vivek Tyagi and Mala Tyagi serve as directors at the Company.
- CIN/LLPIN
U51900MH1990PTC055991
- Company No.
055991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Malade Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Tyagi  | Director | 18-Mar-2019 | Current |
| Mala Tyagi | Director | 03-Oct-2005 | Current |
Financial Performance of Malade Chemicals.
Malade Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.41% increase. The company also saw a substantial improvement in profitability, with a 11.53% increase in profit. The company's net worth Soared by an impressive increase of 23.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Malade Chemicals?
In 2021, Malade Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ind-Expo Oleochemicals Private LimitedActive 33 years 29 daysVivek Tyagi and Mala Tyagi are mutual person
- Sahil Pharma Chemicals Private LimitedActive 26 years 2 months
Vivek Tyagi and Mala Tyagi are mutual person
- Goodluck Metals Private LimitedActive 18 years 6 months
Vivek Tyagi and Mala Tyagi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 07 Sep 2020 | ₹3.80 M | Open |
Syndicate Bank Creation Date: 24 Nov 1995 | ₹2.50 M | Open |
How Many Employees Work at Malade Chemicals?
Unlock and access historical data on people associated with Malade Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Malade Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malade Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
